Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1998-8-24
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0392-856X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
16
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
352
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:9631766-Cyclosporine,
pubmed-meshheading:9631766-Humans,
pubmed-meshheading:9631766-Immunosuppressive Agents,
pubmed-meshheading:9631766-Lung Diseases, Interstitial,
pubmed-meshheading:9631766-Lupus Erythematosus, Systemic,
pubmed-meshheading:9631766-Sjogren's Syndrome,
pubmed-meshheading:9631766-Thrombocytopenia
|
pubmed:articleTitle |
Extremely low dose treatment of cyclosporine for autoimmune diseases.
|
pubmed:publicationType |
Letter,
Case Reports
|